Newsroom

Sorted by: Latest

-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share FIRST TRUST BLOOMBERG GLOBAL SEMICONDUCTOR SUPPLY CHAIN UCITS ETF 26.10.2026 CHPS.LN IE000KXTLDE2  750,002.00 USD  33,318,437.85   44.425  ...
-

Cardo AI Introduces the Asset Based Finance Data Standards for 30 Collateral Types

NEW YORK--(BUSINESS WIRE)--Cardo AI, a leading technology platform for asset-based finance and private credit, has introduced unified data standards across 30 collateral types....
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Moderate Buffer UCITS ETF - May 26.10.2026 GMAY.LN IE000P0FL8E3 1,300,002.00 USD  53,133,598.94   40.872  ...
-

Qube Research & Technologies LTD UK Regulatory Announcement: Form 8.3

LONDON--(BUSINESS WIRE)--  FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION (a) Full name of discloser Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a) The naming of nominee or vehicle companies is insufficient. For a tru...
-

Rumi Therapeutics Announces Licensing Agreement With Enthorin Therapeutics to Advance RTX-7340, an IND-Ready PDE2 Inhibitor, for Fragile X Syndrome

NEW YORK--(BUSINESS WIRE)--Rumi Therapeutics, a drug-development company within Rumi Scientific Holdings, today announced an option to license agreement with Enthorin Therapeutics to advance RTX-7340 (ENT-7340), an investigational phosphodiesterase 2 (PDE2) inhibitor, for the treatment of Fragile X syndrome (FXS). The agreement brings an IND-ready therapeutic candidate into Rumi Therapeutics’ pipeline and represents a significant milestone in Rumi Scientific Holdings’ expansion from discovery-s...
-

TradeStation Brings Extended Hours Options Trading to Clients as Cboe Expands Trading Access

PLANTATION, Fla.--(BUSINESS WIRE)--TradeStation Securities, Inc. (“TradeStation”), the brokerage firm built for active equity and derivatives traders, today announced the launch of extended hours options trading for select single stock and ETF equity options traded on Cboe Options Exchange,* providing TradeStation clients with the ability to trade eligible equity and ETF options during a pre-market session from 7:30 a.m. to 9:25 a.m. ET and an extended curb session from 4:00 p.m. to 4:15 p.m. E...
-

Hewes Named Best US Public Relations and Communications Firm by ETF Express

NEW YORK--(BUSINESS WIRE)--Hewes named Best US Public Relations and Communications Firm at the 2026 ETF Express US ETF Awards....
-

Pictet Asset Management Appoints Rick Bisignano as U.S. Head of Institutional Distribution

NEW YORK--(BUSINESS WIRE)--Pictet Asset Management, headquartered in Geneva, Switzerland, today announced the appointment of Rick Bisignano as U.S. Head of Institutional Distribution. Based in Pictet’s New York office, Mr. Bisignano will lead the firm’s institutional business development and client relationships in the United States, with a focus on public and corporate pension plans, endowments, foundations, insurers and the investment consultants and OCIOs that advise them. He will report to...
-

Motion56 Opens Its Doors: A Data Partner Built for a Rapidly Evolving AI Landscape

LONDON--(BUSINESS WIRE)--Motion56, Newsflare’s AI licensing division, launches to supply AI video training data, metadata and annotation for physical and generative video....
-

Delcath Systems to Participate in Upcoming Investor Conferences

QUEENSBURY, N.Y.--(BUSINESS WIRE)--Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today announced that management will be attending the following investor conferences: UBS Global Healthcare Conference on Tuesday, November 10, 2026 in Palm Beach Gardens, FL Canaccord Genuity's MedTech, Diagnostics and Digital Health & Services Forum on Wednesday, November 11, 2026 in New York, NY Craig-Hallum A...